Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on Karius® — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Karius Secures BARDA Contract to Expand Agnostic Detection of Pathogens

Aug 08, 2024•almost 2 years ago

Contract Type

contract

Redwood CityBiotechnologyHealth CareGeneticsHealth Diagnostics

Description

Karius®, Inc. has been awarded a contract valued over $600,000 from the Division of Research, Innovation, and Ventures (DRIVe), under the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services. The contract enables Karius to extend its current DNA pathogen detection capabilities to include RNA pathogen detection from a variety of human samples.

Company Information

Company

Karius®

Location

Redwood City, California, United States

About

Karius®, Inc. is a world leader in genomic diagnostics for infectious disease, with a focus on extending access to advanced genomic diagnostics and addressing the antimicrobial resistance crisis.

Predictive Intelligence
Strategic

ML-powered predictions for Karius®'s next move

Learn about Strategic plan

Related People

Suggested for you

Sign in to view contact details

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months